# Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

> **NCT00592319** · PHASE2 · TERMINATED · sponsor: **Boston University** · enrollment: 10 (actual)

## Conditions studied

- Laryngeal Papilloma

## Interventions

- **DRUG:** Celebrex
- **DEVICE:** PDL
- **PROCEDURE:** CO2 laser or microsurgery

## Key facts

- **NCT ID:** NCT00592319
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** 03/01/2009,due to date close to termination of this funding/study period
- **Last updated:** 2012-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592319, "Celebrex (Celecoxib) Treatment of Laryngeal Papilloma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00592319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*